USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	066645/0172			Pages:	140
		Recorded:	02/22/2024
Attorney Dkt #:	20443-0001001
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 19

Patent #:	NONE	Issue Dt:		Application #:	14126928	Filing Dt:	12/17/2013
Publication #:	US20140255427	Pub Dt:	09/11/2014
Title:	COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD

Patent #:	NONE	Issue Dt:		Application #:	14127217	Filing Dt:	12/18/2013
Publication #:	US20140227277	Pub Dt:	08/14/2014
Title:	Combination therapy with an anti-CD19 antibody and a purine analog

Patent #:	10617691	Issue Dt:	04/14/2020	Application #:	15572914	Filing Dt:	11/09/2017
Publication #:	US20180153892	Pub Dt:	06/07/2018
Title:	COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF

Patent #:	11224654	Issue Dt:	01/18/2022	Application #:	15752009	Filing Dt:	02/12/2018
Publication #:	US20180228893	Pub Dt:	08/16/2018
Title:	COMBINATIONS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16305482	Filing Dt:	11/29/2018
Publication #:	US20190195879	Pub Dt:	06/27/2019
Title:	METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

Patent #:	11352423	Issue Dt:	06/07/2022	Application #:	16310555	Filing Dt:	12/17/2018
Publication #:	US20190322742	Pub Dt:	10/24/2019
Title:	ANTI-CD19 ANTIBODY FORMULATIONS

Patent #:	NONE	Issue Dt:		Application #:	16342645	Filing Dt:	04/17/2019
Publication #:	US20190241656	Pub Dt:	08/08/2019
Title:	COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16615953	Filing Dt:	11/22/2019
Publication #:	US20210292410	Pub Dt:	09/23/2021
Title:	TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT

Patent #:	NONE	Issue Dt:		Application #:	16806353	Filing Dt:	03/02/2020
Publication #:	US20200206228	Pub Dt:	07/02/2020
Title:	COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16839777	Filing Dt:	04/03/2020
Publication #:	US20200353077	Pub Dt:	11/12/2020
Title:	COMBINATIONS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16839903	Filing Dt:	04/03/2020
Publication #:	US20200352975	Pub Dt:	11/12/2020
Title:	COMBINATIONS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17084751	Filing Dt:	10/30/2020
Publication #:	US20210130460	Pub Dt:	05/06/2021
Title:	ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR LYMPHOMA

Patent #:	NONE	Issue Dt:		Application #:	17084783	Filing Dt:	10/30/2020
Publication #:	US20210130461	Pub Dt:	05/06/2021
Title:	ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS

Patent #:	NONE	Issue Dt:		Application #:	17545274	Filing Dt:	12/08/2021
Publication #:	US20220088197	Pub Dt:	03/24/2022
Title:	COMBINATIONS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17605285	Filing Dt:	10/21/2021
Publication #:	US20220242952	Pub Dt:	08/04/2022
Title:	ANTI-CD19 THERAPY IN PATIENTS HAVING A LIMITED NUMBER OF NK CELLS

Patent #:	NONE	Issue Dt:		Application #:	17700809	Filing Dt:	03/22/2022
Publication #:	US20220213190	Pub Dt:	07/07/2022
Title:	ANTI-CD19 ANTIBODY FORMULATIONS

Patent #:	NONE	Issue Dt:		Application #:	17824266	Filing Dt:	05/25/2022
Publication #:	US20220283166	Pub Dt:	09/08/2022
Title:	METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

Patent #:	NONE	Issue Dt:		Application #:	18087068	Filing Dt:	12/22/2022
Publication #:	US20230357392	Pub Dt:	11/09/2023
Title:	Treatment Paradigm for an Anti-CD19 Antibody Therapy

Patent #:	NONE	Issue Dt:		Application #:	18162955	Filing Dt:	02/01/2023
Publication #:	US20240009196	Pub Dt:	01/11/2024
Title:	COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF

Assignors

Exec Dt:

02/05/2024

Exec Dt:

02/05/2024

Assignee

1801 AUGUSTINE CUT-OFF

WILMINGTON, DELAWARE 19803

Correspondence name and address
	JOHN BRENNAN
	FISH & RICHARDSON P.C.
	P.O. BOX 1022
	MINNEAPOLIS, MN 55440-1022

Search Results as of: 05/10/2024 05:45 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6